FDA Adverse Event Malfunction Summary report: N

HEMICAP RESURFACING SYSTEM - 2.0MM GUIDE PIN

MDR report key: 7971220 · Received October 16, 2018

Report

Report Number
3004154314-2018-00018
Event Type
Malfunction
Date Received
October 16, 2018
Date of Event
February 28, 2018
Report Date
September 24, 2018
Manufacturer
ARTHROSURFACE, INC.
Product Code
LXH
PMA / PMN Number
K031859
Product Problem
Yes
Report Source
User Facility report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO THE REP WHO ATTENDED THE CASE, A 2.0MM GUIDE PIN BROKE WHEN THE SURGEON WAS RE-REAMING THE BONE. THE SURGEON DECIDED TO LEAVE THE BROKEN GUIDE PIN FRAGMENT INSIDE THE BONE AFTER DETERMINING THAT IT WAS DIFFICULT TO RETRIEVE AND DID NOT PENETRATE OR PUNCTURE ANY CORTICAL SURFACE. THE SAME WAS CONVEYED TO THE PATIENT. THE DEVICE HISTORY RECORD OF THE LOT IN QUESTION WAS REVIEWED AND NOTED THAT ALL GUIDE PINS WERE BUILT TO SPECIFICATION. LIKEWISE, THE SALES HISTORY OF THE LOT WAS REVIEWED AND FOUND THAT NO OTHER COMPLAINTS OR ISSUES INDICATING FAILURE OR MALFUNCTION OF THE GUIDE PINS WERE REPORTED TO DATE. FOLLOWING A DISCUSSION WITH THE ENGINEERING DEPARTMENT AND A REVIEW OF SIMILAR COMPLAINTS FROM THE PAST INDICATED USE OF EXCESSIVE OR OFF-AXIAL FORCE TO BE THE CONTRIBUTING FACTORS OF THE REPORTED ISSUE. THE GUIDE PINS ARE GAMMA STERILIZED AND BUILT USING IMPLANT-GRADE MATERIAL (316LVM SST PER ASTM F138). HENCE, NO STERILITY OR BIOCOMPATIBILITY CONCERNS ARE EXPECTED. THERE IS NO DISCERNABLE EVIDENCE THAT THE GUIDE PIN MALFUNCTIONED DUE TO DEFICIENCIES IN THE MANUFACTURING PROCESS.

Description of Event or Problem · 1

THE MANUFACTURER WAS NOTIFIED VIA A MEDWATCH REPORT FILED BY THE USER FACILITY CONCERNING A BROKEN GUIDE PIN DURING A TOE HEMIARTHROSPLASTY PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
810006 HEMICAP RESURFACING SYSTEM - 2.0MM GUIDE PIN ORTHOPEDIC MANUAL SURGICAL INSTRUMENT LXH ARTHROSURFACE, INC. 75AE0607

Patients

Seq Age Sex Outcome Treatment
1 62 YR Other